Elevated serum complement levels and higher gene copy number of complement C4B are associated with hypertension and effective response to statin therapy in childhood-onset systemic lupus erythematosus (SLE)
Objective Systemic lupus erythematosus (SLE) features high frequency of cardiovascular disease (CVD) and fluctuating complement levels. The clinical trial Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) aimed to evaluate whether atorvastatin treatment reduced the progression of a...
Saved in:
| Main Authors: | Evan Mulvihill, Stacy Ardoin, Susan D Thompson, Bi Zhou, Gakit Richard Yu, Emily King, Nora Singer, D M Levy, Hermine Brunner, Yee Ling Wu, Haikady N Nagaraja, Laura Eve Schanberg, Chack-Yung Yu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-12-01
|
| Series: | Lupus Science and Medicine |
| Online Access: | https://lupus.bmj.com/content/6/1/e000333.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cell-bound complement activation products associate with lupus severity in SLE
by: Richard A Furie, et al.
Published: (2020-10-01) -
Associations Between Serum Autoantibodies, Cytokines, Complements, and Clinical Manifestations in SLE Patients
by: Vikas Kailashiya, et al.
Published: (2024-12-01) -
Complement Receptor Type 1 Suppresses Human B Cell Functions in SLE Patients
by: Mariann Kremlitzka, et al.
Published: (2016-01-01) -
Randomised prospective trial to assess the clinical utility of multianalyte assay panel with complement activation products for the diagnosis of SLE
by: Daniel J Wallace, et al.
Published: (2019-12-01) -
Biological functions of complement
by: Yu. N. Odintsov, et al.
Published: (2007-06-01)